NCT02951962

A Study to Investigate Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin

A Phase 1, Open Label, Two-cohort, Single-Sequence, Crossover Study to Investigate the Pharmacokinetic Drug Interaction and Safety of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Yuhan Corporation · Industry
• Sex: Male
• Age: 19 Years – 50 Years
• Healthy volunteers: Accepted

Summary

This is a phase 1, open label, two-cohort, single-sequence, crossover study

Detailed description

This is a phase 1, open label, two-cohort, single-sequence, crossover study to investigate the pharmacokinetic drug interaction and safety of Telmisartan/Amlodipine and Rosuvastatin in healthy male volunteers.

Conditions

• Hypertension
• Hyperlipidemia

Interventions

Type	Name	Description
DRUG	Twynsta 80/5mg	Hypertension
DRUG	Crestor 20mg	Hyperlipidemia

Timeline

• Start date: 2016-08-01
• Primary completion: 2016-09-01
• Completion: 2016-09-01
• First posted: 2016-11-01
• Last updated: 2017-02-01

Locations

1 site across 1 country: South Korea